MPT Resource Center

Male Contraceptive Initiative & IMPT: CT/MPT Fellowship Promotional Webinar

EECO Product Registration Toolkit

EECO Product Registration Toolkit August 2022 click to view Toolkit In this Technical Brief: Product Type(s): Drug Products Topic(s): Inactive Ingredients Region(s): United States

Sexually Transmitted Infections: Public Health Status and Opportunities for Multipurpose Prevention Technologies

Exploring the R&D Landscape and Potential of Multipurpose Prevention Technologies

Considerations when Transitioning an MPT Product Candidate from Preclinical to Clinical Development

Patenting and Intellectual Property Considerations for HIV Prevention & MPTs

Medicines Patent Pool: Licenses

Medicines Patent Pool: Licenses June 2022 click to view Webpage In this Technical Brief: Product Type(s): Long-Acting Therapeutics Topic(s): Licenses Region(s): United States, L/MICs

The Long-Acting Technologies Patents and Licenses Database

The Long-Acting Technologies Patents and Licenses Database June 2022 click to view Webpage In this Technical Brief: Product Type(s): Long-Acting Therapeutics Patents and Licenses Database Medicines Patent Pool Topic(s): Licenses Patents Long-Acting Technologies Region(s): United States, L/MICs

Integrating End-User Research in MPT Product Development & Commercialization Strategies

A Thought Paper on Fostering Greater Utilization of Social and Behavioural Research in The Development Setting and Creating Impact

Sexual Satisfaction Results With the Vaginal pH Modulator From the Phase 3 AMPOWER Study

MPT Regulatory Pathways: Case Studies From MPT Product Developers

Glossary of Regulatory Terms

Glossary of Regulatory Terms Feb 2022 click to view Guidance Document In this Technical Brief: Topic(s): Regulatory Terms Glossary Region(s): United States

Word on the Street: African Women Share Their Reproductive Health Stories

HIV prevention: better choice for better coverage

Inactive Ingredient Search for Approved Drug Products

Inactive Ingredient Search for Approved Drug Products January 2022 click to view Guidance Document In this Technical Brief: Product Type(s): Drug Products Topic(s): Inactive Ingredients Region(s): United States

Principles of Premarket Pathways for Combination Products

Principles of Premarket Pathways for Combination Products – Guidance for Industry and FDA Staff January 2022 click to view Guidance Document In this Technical Brief: Health Risk(s): Combination Products Product Type(s): Combination Topic(s): Regulatory Issues Region(s): United States

Medicines Patent Pool: Long-Acting Therapeutics

Medicines Patent Pool: Long-Acting Therapeutics December 2021 click to view Webpage In this Technical Brief: Product Type(s): Long-Acting Therapeutics Topic(s): Expanding Access to Long-acting Therapeutics in LMICs Region(s): United States, L/MICs

Multipurpose Prevention Technologies: Technology Landscape and Potential for Low- and Middle-Income Countries

Multipurpose Prevention Technologies: Technology Landscape and Potential for Low- and Middle-Income Countries View Report December, 2021 In this Report: Topic(s): Multipurpose Prevention Technology Pipeline Landscape

Introducing New Contraceptive Options: Product Registration Basics for Global Health Program Managers

Introducing New Contraceptive Options: Product Registration Basics for Global Health Program Managers In this Report: Topic(s): Regulatory Pathways Global Health Contraception

Advancing Self-Care with Multipurpose Prevention Technologies (MPTs)

Featured in the CTI Exchange’s Beginning with the End in Mind series, CAMI Health joins the nuanced conversation surrounding self-care within the sexual and reproductive health domain by highlighting the unique contributions and benefits of multipurpose prevention technologies (MPTs).

Can Fantasies Become Realities? The Quest for Multipurpose Prevention Products

Advances in long-acting injectables, implants, and vaginal rings for contraception and HIV prevention

Multipurpose Prevention Technologies: Opportunities and Challenges to Ensure Advancement of the Most Promising MPTs

Annual National Reproductive Health Conference

10-13 August 2021 Annual National Reproductive Health Conference San Francisco, CA, USA

Dual Prevention Pill: A Summary of Insights and Recommendations on the uptake of the combined PrEP and Oral Contraceptive pill by women of reproductive age in South Africa and Zimbabwe

Recommendations and Solutions from Human-Centered Design Research on the Dual Prevention Pill

Giving Voice to the End-User: Input on Multipurpose Prevention Technologies From the Perspectives of Young Women in Kenya and South Africa

Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake

MPT Mini Video Series

The IMPT introduces its MPT Mini Video Series, a new audiovisual project aimed to raise awareness about MPTs and bring digestible bits of the MPT story to your fingertips. The series kicks off with an introduction to the first-ever MPT in “King Minos & the First Condom.” In the second video, “If I Could Talk to the Scientists…”, we hear first-hand from health professionals at Wits RHI on the potential of MPTs to improve sexual and reproductive health. Stay tuned for upcoming videos in the series bringing you more voices from women around the world.

Compounds with Potential Activity to Prevent or Treat HIV and Other Sexually Transmitted Infections: A Landscape Review

Compounds with Potential Activity to Prevent or Treat HIV and Other Sexually Transmitted Infections: A Landscape Review July, 2021 click to view Report In this Report: Topic(s): Compounds with Multiple Potential Activities

Opportunities and Challenges for MPT & HIV Prevention Drug Delivery Approaches

New Frontiers in STI/HIV Prevention & Family Planning: The Promise of Multipurpose Prevention Technologies

Combining Active Pharmaceutical Ingredients: MPT Development & Regulatory Considerations

Microarray patches: Breaking down the barriers to contraceptive care and HIV prevention for women across the globe

MPTs & the IMPT Platform

MPTs & the IMPT Platform May 2021 The MPTs & the IMPT Platform is a PowerPoint presentation created by the IMPT Secretariat at CAMI Health to help our colleagues integrate MPTs into their talks and presentations. Please email IMPT@cami-health.org with any feedback on how you used this information. Download the presentation slide deck CAMI Health […]

Toxicity study considerations for HIV prevention and MPT R&D

Advocates’ Guide to Multipurpose Prevention Technologies

The Power of MPTs: Combining Prevention of HIV, other STIs, and Pregnancy

The Power of MPTs: Combining Prevention of HIV, other STIs, and Pregnancy The IMPT’s Susanna Moore, Bethany Young Holt, and IMPT Advisory Council Member Thesla Palanee-Philips of Wits Reproductive Health and HIV Institute (Wits RHI), University of the Witwatersrand, presented an introductory MPT panel at USAID’s Global Health Science and Practice Technical Exchange (GHTechX) in […]

Integrating Socio-behavioral & Market Research into MPT R&D: Applying Lessons Learned

TRIO Study Brief: Long-Acting Injections for Women’s HIV Prevention in Sub-Saharan Africa: What End-Users Think

Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial

Microbicide Trials Network (MTN) Socio-behavioral Research Compendium

Multipurpose Prevention Technologies: Strategy recommendations to guide the most promising products from the lab to hands of women

Multipurpose Prevention Technologies: Strategy recommendations to guide the most promising products from the lab to hands of women January, 2021 Recent results from long-acting HIV prevention trials in parallel with the MPTs in the pipeline herald an exciting time for the MPT field. However, given finite resources and technical challenges to advance products from preclinical […]

The role of cervicovaginal microbiota on contraceptive and MPT development

Donation of Contraceptive Products through Special Import Permits: A Case Study in Zambia and Nigeria

Donation of Contraceptive Products through Special Import Permits: A Case Study in Zambia and Nigeria December 2020 click to view Guidance Document In this Technical Brief: Topic(s): Contraceptive Products Special Import Permits Region(s): Zambia Nigeria

HIV prevention is not all about HIV – using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protection

Use of International Standard ISO 10993-1, “Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process”

Use of International Standard ISO 10993-1, “Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process” September 2020 click to view Guidance Document In this Technical Brief: Product Type(s): Medical Devices Topic(s): Product Development Regulatory Issues Region(s): United States

MCI’s Lemonade Stand Series: “Multipurpose Prevention Technologies (MPTs) & Male Contraception”

Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake